Peripheral Arterial Disease Trial, Recruiting NCT06713850 Sponsor: Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06713850
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People whose leg artery symptoms fall within a specific range of severity, known as Rutherford Classification 2–5 (confirm with trial site for what this means for your situation)
  • People who have a significant narrowing (more than 70%) or complete blockage of the main artery running along the thigh and behind the knee, with at least one healthy, open blood vessel pathway continuing below the knee and down to the ankle, confirmed by a specialised imaging test called a DSA
  • People who understand the purpose of the study, are willing to take part voluntarily, sign a consent form, and are willing to attend follow-up appointments
  • People whose blockage can be crossed with a medical guidewire during the procedure
  • People with a life expectancy of more than 24 months
  • People with moderately severe calcium build-up in the affected artery, confirmed by imaging
  • People who need treatment in both legs may be enrolled, with each leg treated one at a time in order
  • People who have already had a procedure to open a blockage in the aorta or iliac arteries (the large arteries in the abdomen and pelvis), where less than 50% narrowing remains after that procedure

Who may not be able to join:

  • People who have had a stroke, bleeding in the brain, bleeding in the digestive system, or a heart attack within the 3 months before joining the trial
  • People with a known allergy to heparin, aspirin, other blood-thinning or antiplatelet medicines, or contrast dye used in imaging
  • People who have taken part in another medication trial within the last 3 months, or who have had other specialised artery-preparation devices used during a procedure (such as plaque-removal devices or special balloons)
  • Women who are pregnant or breastfeeding
  • People who are unable or unwilling to take part in the trial
  • People diagnosed with Buerger's disease (a condition affecting blood vessels in the arms and legs)
  • People who have already had an arterial bypass surgery on the leg being considered for treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-13545160302

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 November 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Procedural Success Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov